The $749 Nonclinical Strategy Audit
That Can Save You Seven Figures

A forensic, founder-level assessment of your entire nonclinical program before you spend real CRO money.

WHAT YOU GET

Within 5 business days you will receive:

A strategic assessment of nonclinical program
Identified risks & readiness gaps
CRO alignment considerations
Regulatory submission friction points
Study sequencing & timing map
Priority action roadmap
60-minute readout call

Book Your Audit

MORE DETAILS

Who is this for?

Pre-IND and IND-bound companies
Programs selecting species and models now
Teams outsourcing all tox to CROs
Founders who want nonclinical leadership
Established startups without in-house tox

What is this for?

✅ This is a strategic diagnostic
✅ This is decision-level analysis

❌ This is not a protocol review

❌ This is not a literature summary
❌ This is not a CRO deliverable critique

Seeking fractional tox support?

The Nonclinical Strategy Audit is a great first step for teams seeking Fractional Toxicology Support. It allows for a thorough assessment of your nonclinical program to ensure alignment and fit. Fractional Toxicology Leadership is intentionally capped at three clients to maintain the depth and quality of support.

I want to discuss Fractional Tox Support directly

INVESTMENT

$749, one-time

If this audit prevents even a single misplaced study, it has already paid for itself.

Book & Pay Now

Request Invoice

The $749 Nonclinical Strategy Audit That Can Save You Seven Figures